News

MassDevice9d
FDA approves Abbott mitral valve replacement device that doesn’t require open-heart surgery
Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...
Medical Device Network on MSN8d
FDA approves Abbott’s TMVR system to treat mitral valve disease
The US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement ...
medtechdive8d
Abbott wins FDA approval for mitral valve replacement device, teeing up Edwards competition
Abbott said the Tendyne system addresses a significant unmet need, providing an option for patients ineligible for open heart surgery and whose valves cannot be successfully repaired with MitraClip.
TCTMD7d
Tendyne Approved in US for High-risk Patients With Mitral Valve Disease
The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...
Investing8d
Abbott’s Tendyne valve gets FDA nod for mitral replacement
The Tendyne system is designed for those who are considered high-risk for traditional open-heart surgery and for whom mitral valve repair with Abbott’s MitraClip is not a viable option. The FDA’s ...
Fierce Biotech9d
Abbott snags US approval for Tendyne mitral valve replacement implant
The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...
Abbott Gains FDA Approval for Tendyne™, Strengthening Its Minimally Invasive Heart Portfolio
Abbott Laboratories (NYSE:ABT) has received FDA approval today for its Tendyne™ transcatheter mitral valve replacement (TMVR) ...
Investing9d
Abbott’s Tendyne valve gets FDA nod for mitral replacement
The Tendyne system is designed for those who are considered high-risk for traditional open-heart surgery and for whom mitral valve repair with Abbott’s MitraClip is not a viable option.